A hydrogen peroxide economizer for on-demand oxygen production-assisted robust sonodynamic immunotherapy

Qinqin Jiang,Bin Qiao,Xiaohong Lin,Jin Cao,Nan Zhang,Huanling Guo,Weiwei Liu,Lingyu Zhu,Xue Xie,Li Wan,Rui Tang,Bing Liang,Dong Wang,Zhigang Wang,Yang Zhou,HaiTao Ran,Pan Li
DOI: https://doi.org/10.7150/thno.64862
IF: 11.6
2022-01-01
Theranostics
Abstract:The outcome of sonodynamic immunotherapy is significantly limited by tumor hypoxia. To overcome this obstacle, one common solution is to catalyze the conversion of endogenous H<sub>2</sub>O<sub>2</sub> into O<sub>2</sub>. However, the effectiveness of this strategy is limited by the insufficient concentration of H<sub>2</sub>O<sub>2</sub> in the tumor microenvironment (TME). Herein, we developed a H<sub>2</sub>O<sub>2</sub> economizer for on-demand O<sub>2</sub> supply and sonosensitizer-mediated reactive oxygen species production during ultrasound activation, thereby alleviating hypoxia-associated limitations and augmenting the efficacy of sonodynamic immunotherapy. <b>Methods:</b> The H<sub>2</sub>O<sub>2</sub> economizer is constructed by electrostatic adsorption and π-π interactions between the Fe-doped polydiaminopyridine (Fe-PDAP) nanozyme and chlorin e6. By employing a biomimetic engineering strategy with cancer cell membranes, we addressed the premature leakage issue and increased tumor-site accumulation of nanoparticles (membrane-coated Fe-PDAP/Ce6, MFC). <b>Results:</b> The prepared MFC could significantly attenuate the catalytic activity of Fe-PDAP by reducing their contact with H<sub>2</sub>O<sub>2</sub>. Ultrasound irradiation promoted MFC dissociation and the exposure of Fe-PDAP for a more robust O<sub>2</sub> supply. Moreover, the combination of MFC-enhanced sonodynamic therapy with anti-programmed cell death protein-1 antibody (aPD-1) immune checkpoint blockade induced a strong antitumor response against both primary tumors and distant tumors. <b>Conclusion:</b> This as-prepared H<sub>2</sub>O<sub>2</sub> economizer significantly alleviates tumor hypoxia via reducing H<sub>2</sub>O<sub>2</sub> expenditure and that on-demand oxygen-elevated sonodynamic immunotherapy can effectively combat tumors.
medicine, research & experimental
What problem does this paper attempt to address?